Cargando…
Frequency of Urinary Tract Infections in Type 2 Diabetic Patients Taking Dapagliflozin
Background Urinary tract infections (UTIs) are common in patients with diabetes. The use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) to achieve good glycemic control increases glucose levels in urine. This glycosuria further enhances the risk of UTIs. This study aimed to evaluate the frequ...
Autores principales: | Khan, Sarfaraz, Hashmi, Mubashar Sultan, Rana, Muhammad A, Zafar, Ghulam Mujtaba, Asif, Sadia, Farooq, Muhammad Talha, Zahoor, Sarmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887691/ https://www.ncbi.nlm.nih.gov/pubmed/35251794 http://dx.doi.org/10.7759/cureus.21720 |
Ejemplares similares
-
LBSUN291 Fournier's Gangrene In A Diabetic Male Taking Dapagliflozin
por: Patel, Janki M, et al.
Publicado: (2022) -
Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis
por: Iqbal, Iqra, et al.
Publicado: (2019) -
Euglycemic Diabetic Ketoacidosis in a Patient With Urinary Tract Infection
por: Patlolla, Sridhar Reddy, et al.
Publicado: (2023) -
The Outcomes of Dapagliflozin Use in Real-Life Clinical Settings in Endocrinology Clinics of Islamabad, Pakistan
por: Kamin, Matiullah, et al.
Publicado: (2020) -
Clinical and Microbiological Profile of Urinary Tract Infections in Diabetic versus Non-Diabetic Individuals
por: Kumar, Ravi, et al.
Publicado: (2019)